{
 "PrintNo":"S6253","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2021-04-19T13:52:13.689034Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-04-19","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1235,"Name":"Daphne Jordan","Short":"JORDAN"}],
 "Title":"Relates to including substances designated pursuant to the federal Analog Act and Controlled Substances Act within the definition of controlled substances",
 "Summary":"Relates to including substances designated pursuant to the federal Analog Act and Controlled Substances Act within the definition of controlled substances.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to including substances designated pursuant to the federal Analog Act and Controlled Substances Act within the definition of controlled substances",
 "PreviousVersions":["S6636-2019"]
}